z-logo
open-access-imgOpen Access
Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006–2015
Author(s) -
Helen PetousisHarris,
Anna S. Howe,
Janine Paynter,
Nikki Turner,
Jennifer Griffin
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy570
Subject(s) - medicine , pneumococcal conjugate vaccine , retrospective cohort study , cohort , conjugate , pediatrics , streptococcus pneumoniae , surgery , antibiotics , microbiology and biotechnology , biology , mathematical analysis , mathematics
Hospitalization rates for infectious diseases in New Zealand (NZ) children have increased since 1989. The highest burden is among Māori and Pacific children, and the most socioeconomically deprived. New Zealand introduced pneumococcal conjugate vaccine (PCV)7 in June 2008, PCV10 in 2011, and PCV13 in 2014.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom